Skip to main content

Table 2 Baseline characteristics of patients (N = 39)

From: The effect of using blood culture bottle of bronchoalveolar larvage fluid in pneumonia

Variables

N (%)

Age (years)

  Median (range)

70.5 (37–93)

Male

27 (69.2)

Category of pneumonia

  CAP

21 (53.8)

  HCAP

6 (15.4)

  HAP & VAP

12 (30.8)

Comorbidities

  Diabetes mellitus

5 (12.5)

  Solid organ malignancy

11 (27.5)

  Hematologic malignancy

2 (5)

  Chronic respiratory disease

8 (20.5)

  HIV infection

1 (2.6)

  Antibiotics started on admission

38 (97.4)

  Antibiotics started within 24 h before BAL

13 (33.3)

  Duration of antibiotics before bronchoscopy (days), mean ± SD

5.8 ± 6.4

  Leukocytes (per mm3), mean ± SD

11,226 ± 5056

  C-reactive protein (mg/dL), mean ± SD

11.74 ± 8.24

Pneumonia outcome

  Improved

31 (77.5)

  Transferred out

1 (2.5)

  Died

7 (17.5)